Professional Resources
There are many resources available to help you diagnose and effectively manage patients with AAT Deficiency.
In this section, you will find our interactive educational program about AAT Deficiency as well as an interview with Dr. John Butler, a pulmonary and critical care specialist.
We offer complimentary AlphaTest® Kits and an AAT Physician Kit. You can help your patient get started on ARALAST NP therapy with the Easy Start Sample Program.
You will also find information about upcoming conferences, a current events News Room, links to association websites, and a listing of article reprints available to you from Baxter.
ARALAST NP [Alpha1-Proteinase Inhibitor (Human)]
ARALAST NP is indicated for chronic augmentation therapy in patients having congenital deficiency of A1-PI with clinically evident emphysema. ARALAST NP is not indicated as therapy for lung disease patients in whom congenital A1-PI deficiency has not been established.
The effect of augmentation therapy with ARALAST NP on pulmonary exacerbations and on the progression of emphysema in alpha1-antitrypsin deficiency has not been demonstrated in randomized, controlled clinical trials.
Please review the Important Risk Information and the Full Prescribing Information
Please review the Important Risk Information and the Full Prescribing Information
